Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/31961
Title: The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population -Based Cohort Study
Authors: Abtahi, Shahab
Burden, Andrea M.
GEUSENS, Piet 
van Staa, Tjeerd
VAN DEN BERGH, Joop 
de Vries, Frank
Issue Date: 2020
Publisher: ELSEVIER SCIENCE INC
Source: Journal of the American Medical Directors Association, 21 (6) , p. 811 -816
Abstract: Bisphosphonates (BPs) might have extra benefits in reducing mortality because of their anti-atherosclerotic effects, but studies reported conflicting results. We investigated the association between oral BP use and mortality risk following a major osteoporotic fracture (MOF) in the United Kingdom.
Notes: de Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Univ Weg 99, NL-3584 CG Utrecht, Netherlands.
f.devries@uu.nl
Other: de Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Univ Weg 99, NL-3584 CG Utrecht, Netherlands. f.devries@uu.nl
Keywords: Intima-Media Thickness;Hip Fracture;Zoledronic Acid;Alendronate;Disease;Women;Calcification;Metaanalysis;Prevention;Men
Document URI: http://hdl.handle.net/1942/31961
ISSN: 1525-8610
e-ISSN: 1538-9375
DOI: 10.1016/j.jamda.2019.11.003
ISI #: WOS:000542142700017
Rights: 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Category: A1
Type: Journal Contribution
Validations: ecoom 2021
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
The Association of Oral Bisphosphonate .pdf
  Restricted Access
Published version293.39 kBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.